Unichem Laboratories

Unichem Laboratories Current Assets

The Current Assets of Unichem Laboratories (UNICHEMLAB.NS) as of Oct 29, 2026 is 20.07 B INR. In the previous year, Current Assets was 17.22 B INR — a change of 16.56% (higher).

Current Assets

20.07 BINR

YoY

16.56%

Last updated:

Current Assets of Unichem Laboratories is 2025 20.07 B INR. Current Assets of Unichem Laboratories was 2024 17.22 B INR. It decreases by 16.56% higher compared to the previous year.

The Unichem Laboratories Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
23.20 B INR
Jan 1, 2019
20.21 B INR
Jan 1, 2020
16.68 B INR
Jan 1, 2021
13.58 B INR
Jan 1, 2022
16.24 B INR
Jan 1, 2023
15.65 B INR
Jan 1, 2024
17.22 B INR
Jan 1, 2025
20.07 B INR
The Unichem Laboratories Current Assets history
YEARCurrent AssetsYoY
20.07 BINR+16.56%
17.22 BINR+10.04%
15.65 BINR-3.63%
16.24 BINR+19.55%
13.58 BINR-18.58%
16.68 BINR-17.46%
20.21 BINR-12.89%
23.20 BINR+216.34%
7.33 BINR+25.71%
5.83 BINR+3.70%
5.63 BINR-2.32%
5.76 BINR+20.38%
4.79 BINR+8.87%
4.40 BINR+3.44%
4.25 BINR+23.77%
3.43 BINR+5.60%
3.25 BINR+24.37%
2.61 BINR-7.86%
2.84 BINR-2.41%
2.91 BINR+13.16%
2.57 BINR+47.56%
1.74 BINR+26.43%
1.38 BINR+46.96%
937.00 MINR+14.41%
819.00 MINR+19.56%
685.00 MINR+14.17%
600.00 MINR-1.80%
611.00 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Unichem Laboratories Stock analysis

What does Unichem Laboratories do? Unichem Laboratories Ltd. generates revenue through the manufacturing and marketing of pharmaceutical formulations, including branded generics and generics across global markets. The company develops and produces complex active pharmaceutical ingredients (API) and dosage forms, targeting therapeutic areas such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives, and pain management. Its subsidiaries, Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta, and Niche Generics Limited UK, support its international operations. Contract manufacturing services for immediate-release and extended-release dosage forms, dry powder injections, syrups, and novel drug delivery systems also contribute to its revenue streams. The company sells its products to healthcare providers, hospitals, and pharmacies worldwide, leveraging its focus on product development and process chemistry. Unichem Pharmaceuticals (USA) Inc and Unichem Farmaceutica Do Brasil Lta serve as key regional entities for market expansion, while Niche Generics Limited UK facilitates operations in the European market. The firm's portfolio includes both branded generics and generic formulations, catering to diverse therapeutic needs across multiple geographies. Unichem Laboratories Ltd. emphasizes technology transfer and documentation in its contract manufacturing services, which are sought by partners in the pharmaceutical industry. The company's product range addresses critical healthcare segments, ensuring consistent demand for its formulations. Its global presence, supported by subsidiaries in the USA, Brazil, and the UK, enables it to serve international clients effectively. Unichem Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Unichem Laboratories stock

Current Assets of Unichem Laboratories is 20.07 B INR in 2025.

Current Assets of Unichem Laboratories changed from 17.22 B INR to 20.07 B INR, representing a 16.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Unichem Laboratories since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Unichem Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Unichem Laboratories

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Unichem Laboratories